Profile - To The Moon

lalabear

Posts · 43Posts · 43
Following · 0Following · 0
Followers · 0Followers · 0

- lalabearlalabear
  ·2022-03-20
  Hold first
  Sorry, this post has been deleted
  2.19K Comment
  3
  Share
  Report
- lalabearlalabear
  ·2022-03-11
  Nice
  7 Cathie Wood Stocks That Are Worth Buying in March
  ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK In
  7 Cathie Wood Stocks That Are Worth Buying in March
  1.82K Comment
  4
  Share
  Report
- lalabearlalabear
  ·2021-09-18
  Agree
  Sorry, this post has been deleted
  3.30K 2
  7
  Share
  Report
- lalabearlalabear
  ·2021-09-15
  Yes
  Sportradar fell 0.83% on its first day of trading
  Online betting company Sportradar opened at $27 each on Tuesday. Everything To Like About The Sport
  Sportradar fell 0.83% on its first day of trading
  2.06K Comment
  4
  Share
  Report
- lalabearlalabear
  ·2021-09-13
  Good
  US IPO Week Ahead: The Fall IPO market kicks off with a 10 IPO week
  After a wave of launches in the short holiday week, 10 IPOs are scheduled to raise over $3 billion i
  US IPO Week Ahead: The Fall IPO market kicks off with a 10 IPO week
  2.23K Comment
  4
  Share
  Report
- lalabearlalabear
  ·2021-09-09
  Good
  Arqit Quantum Shares Up More Than 45% Wednesday
  Shares of quantum encryption technology company Arqit Quantum Inc. are higher on the Nasdaq Wednesda
  Arqit Quantum Shares Up More Than 45% Wednesday
  3.01K 1
  5
  Share
  Report
- lalabearlalabear
  ·2021-09-07
  Good
  Sorry, this post has been deleted
  3.06K 1
  2
  Share
  Report
- lalabearlalabear
  ·2021-09-06
  Agree
  Beat the market with this quant system that’s very bullish on stocks at record highs
  Vance Howard’s HCM Tactical Growth Fund moves you in and out of the stock market when prudent to do
  Beat the market with this quant system that’s very bullish on stocks at record highs
  2.12K Comment
  5
  Share
  Report
- lalabearlalabear
  ·2021-09-02
  Yes
  Sorry, this post has been deleted
  2.02K Comment
  3
  Share
  Report
- lalabearlalabear
  ·2021-09-01
  Wow
  Sorry, this post has been deleted
  3.04K 2
  5
  Share
  Report

Most Discussed

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"4087621400674580","uuid":"4087621400674580","gmtCreate":1624518589117,"gmtModify":1626584757277,"name":"lalabear","pinyin":"lalabear","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/a1763b48ffed5396b0f7f8ce408d9a00","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":5,"headSize":128,"tweetSize":43,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.09.17","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":9034936145,"gmtCreate":1647750144717,"gmtModify":1676534263076,"author":{"id":"4087621400674580","authorId":"4087621400674580","name":"lalabear","avatar":"https://static.tigerbbs.com/a1763b48ffed5396b0f7f8ce408d9a00","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087621400674580","idStr":"4087621400674580"},"themes":[],"htmlText":"Hold first","listText":"Hold first","text":"Hold first","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9034936145","repostId":"2220430742","repostType":4,"isVote":1,"tweetType":1,"viewCount":2187,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9036975129,"gmtCreate":1646973442277,"gmtModify":1676534183692,"author":{"id":"4087621400674580","authorId":"4087621400674580","name":"lalabear","avatar":"https://static.tigerbbs.com/a1763b48ffed5396b0f7f8ce408d9a00","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087621400674580","idStr":"4087621400674580"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9036975129","repostId":"1195233805","repostType":4,"repost":{"id":"1195233805","kind":"news","pubTimestamp":1646960442,"share":"https://ttm.financial/m/news/1195233805?lang=&edition=fundamental","pubTime":"2022-03-11 09:00","market":"us","language":"en","title":"7 Cathie Wood Stocks That Are Worth Buying in March","url":"https://stock-news.laohu8.com/highlight/detail?id=1195233805","media":"InvestorPlace","summary":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK In","content":"<div>\n<p>ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These ...</p>\n\n<a href=\"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/\">Web Link</a>\n\n</div>\n","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Cathie Wood Stocks That Are Worth Buying in March</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Cathie Wood Stocks That Are Worth Buying in March\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-11 09:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These ...</p>\n\n<a href=\"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","MELI":"MercadoLibre","VRTX":"福泰制药","SPOT":"Spotify Technology S.A.","ROKU":"Roku Inc","PATH":"UiPath","U":"Unity Software Inc."},"source_url":"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1195233805","content_text":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:Mercadolibre(NASDAQ:MELI)Roku(NASDAQ:ROKU)Spotify Technology(NYSE:SPOT)Teladoc Health(NYSE:TDOC)UiPath(NYSE:PATH)Unity Software(NYSE:U)Vertex Pharmaceuticals(NASDAQ:VRTX)Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.","news_type":1,"symbols_score_info":{"SPOT":0.9,"MELI":0.9,"VRTX":0.9,"TDOC":0.9,"ROKU":0.9,"PATH":0.9,"U":0.9}},"isVote":1,"tweetType":1,"viewCount":1816,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":884272523,"gmtCreate":1631903907862,"gmtModify":1676530666375,"author":{"id":"4087621400674580","authorId":"4087621400674580","name":"lalabear","avatar":"https://static.tigerbbs.com/a1763b48ffed5396b0f7f8ce408d9a00","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087621400674580","idStr":"4087621400674580"},"themes":[],"htmlText":"Agree&nbsp;","listText":"Agree&nbsp;","text":"Agree","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/884272523","repostId":"2168885573","repostType":4,"isVote":1,"tweetType":1,"viewCount":3299,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":882992786,"gmtCreate":1631637384745,"gmtModify":1676530597645,"author":{"id":"4087621400674580","authorId":"4087621400674580","name":"lalabear","avatar":"https://static.tigerbbs.com/a1763b48ffed5396b0f7f8ce408d9a00","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087621400674580","idStr":"4087621400674580"},"themes":[],"htmlText":"Yes","listText":"Yes","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/882992786","repostId":"1149444561","repostType":4,"repost":{"id":"1149444561","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1631637038,"share":"https://ttm.financial/m/news/1149444561?lang=&edition=fundamental","pubTime":"2021-09-15 00:30","market":"us","language":"en","title":"Sportradar fell 0.83% on its first day of trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1149444561","media":"Tiger Newspress","summary":"Online betting company Sportradar opened at $27 each on Tuesday.\n\nEverything To Like About The Sport","content":"<p>Online betting company Sportradar opened at $27 each on Tuesday.</p>\n<p><img src=\"https://static.tigerbbs.com/50aafa6b5817c8055173c9017ac900d2\" tg-width=\"1080\" tg-height=\"2240\" referrerpolicy=\"no-referrer\"></p>\n<p>Everything To Like About The Sportradar IPO</p>\n<p><b>Summary</b></p>\n<ul>\n <li>Sportradar Group AG is preparing to go public at a valuation of $7.8 billion and will raise over $500 million.</li>\n <li>Sportradar plays an important, though indirect role in the rapidly growing sports betting industry. However, it faces tough competition.</li>\n <li>Sportradar’s finances are in good shape with high growth and a positive net profit, and its valuation appears low relative to competitors.</li>\n <li>Investors should strongly consider this company when it goes public.</li>\n</ul>\n<p>Sportradar (NASDAQ:SRAD) has released pricing information about its upcoming IPO.Renaissance Capitalreported on Tuesday that Sportradar “plans to raise $504 million by offering 19 million shares at a price range of $25 to $28,” as well as an additional $159 million concurrent private placement. This will give the Swiss company a valuation of $7.8 billion at the midpoint range.</p>\n<p>These numbers may be a tiny disappointment for Sportradar, as it had been reportedly shooting for a$10 billion valuationearlier in the year by undergoing a SPAC. But it is great news for investors, as there is a great deal to like about Sportradar. The sports company is in a market with major growth potential, is profitable, and has been growing rapidly. Concerns remain such as COVID and other competition, but investors should strongly consider getting in on this company as soon as possible especially compared to its main competitors.</p>\n<p><b>Sports Gambling Market Potential</b></p>\n<p>Sports betting has become increasingly accepted and thus a more lucrative market in recent years, as governments have legalized it for the first time.Front Office Sportsreported in June that the US sports betting market could reach $37 billion by 2025 compared to its present value of $9.5 billion. Furthermore, the global sports betting market could reach as much as $144 billion by the same timeframe. And while there are some concerns due to COVID, it is highly unlikely that sports leagues will once again start canceling their events going forward.</p>\n<p>Sportradar’s plan is to be the company selling shovels in this betting gold rush. What it intends to sell is information. Sportradar works with sports leagues across the world to help compile sports data. This data helps betting companies set better odds, helps bettors know that the betting company is not making any mistakes, and helps media companies know that they have the right data.</p>\n<p>The right data is not just about tracking points, home runs, or touchdowns. Sportradar claims in itsF-1/Athat it tracks “over 1.2 billion live data points per year from over 600,000 events in 37 sports,” which created over 21 billion odds changes. Furthermore, Sportradar has a strong data rights portfolio, as it has partnerships with the NBA, MLB, and NHL among other sports leagues across the world.</p>\n<p>These factors point to a company with major growth potential, but then there is the issue of competition. Sportradar’s primary competitor is Genius Sports (NYSE:GENI), which went public this April. After some stumbles a few weeks back, Genius has performed well and has a market cap of $4.23 billion as of the time of writing. While smaller than what Sportradar is aiming for, Genius does have a prized partnership with the NFL and reported a revenue growth of 108% a few days ago perCNBC.</p>\n<p>Sportradar will need to show how it can continue to distinguish itself from its competitors like Genius, as well as Stats Perform, IMGArena, and BetConstruct. But the company has a Dollar-Based Net Retention Rate of 138% which shows an ability to keep customers. Furthermore, the massive potential of the sports betting market means that Sportradar will be able to keep growing without having to poach from competitors.</p>\n<p><b>Finances and Valuation</b></p>\n<p>Sportradar’s growth potential is shown by its finances, where it is the rare tech company which can report both high growth and profitability. The company reported a revenue of $318 million in the first half of 2021, up 42% from the same time period last year. This is probably elevated due to the pandemic depressing 2020 revenue as it only grew 6% in 2020, but Sportradar reports a CAGR of 25% going back to 2016. That is a more reasonable yet still sufficient growth rate.</p>\n<p>Furthermore, Sportradar reported a net income of over $20 million in the first half of 2021 and has a history of profitability going back to at least 2019. Cash flow is also positive, with a net gain of $67 million in cash from operating activities in the first half of 2021.</p>\n<p>Finally, Sportradar reports having $223 million in cash against $967 million in total liabilities. What these numbers show is that Sportradar is rapidly growing, though admittedly not as fast as Genius Sports. But unlike Genius, Sportradar is larger and reports a profit.</p>\n<p></p>\n<p>The next question thus becomes whether Sportradar is worth $7.8 billion. At that market cap, Sportradar has an enterprise value of about $8.5 billion. If we just extrapolate Sportradar’s revenue for the entire year and presume a revenue of $636 million, this gives an EV/revenue ratio of 13.36. By contrast, Genius Sports has an enterprise value of nearly $4 billion, and its first half 2021 revenue was just $109.5 million. From that metric, Sportradar thus appears to be the safer long-term bet.</p>\n<p><b>Final Thoughts</b></p>\n<p>While there is a great deal to like about Sportradar, that does not suggest that there are no problematic clouds on the horizon. I believe that the current COVID situation, where many are reluctant to go outside but sports games are still ongoing, is an excellent situation for Sportradar as people watching from home are more likely to bet online. But if it worsens and sports events are canceled, that would be problematic. If it improves, people may start going for other entertainment options such as casinos which could hurt Sportradar’s growth.</p>\n<p>But Sportradar has shown an ability to consistently grow and is in a market which has major potential almost regardless of the state of COVID. Its financial numbers are in solid shape, and few companies provide a product like what it offers. Finally, its valuation of $7.8 billion is eminently fair, especially by the standards of a typical tech company IPO.</p>\n<p>Investors who chase growth above all else may want to consider Genius, especially as Genius’s lockup period expires soon and it is reasonable to expect a decrease in the price then. But for investors interested in a good tech IPO at a reasonable price, Sportradar will be an excellent fit for most.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sportradar fell 0.83% on its first day of trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSportradar fell 0.83% on its first day of trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-15 00:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Online betting company Sportradar opened at $27 each on Tuesday.</p>\n<p><img src=\"https://static.tigerbbs.com/50aafa6b5817c8055173c9017ac900d2\" tg-width=\"1080\" tg-height=\"2240\" referrerpolicy=\"no-referrer\"></p>\n<p>Everything To Like About The Sportradar IPO</p>\n<p><b>Summary</b></p>\n<ul>\n <li>Sportradar Group AG is preparing to go public at a valuation of $7.8 billion and will raise over $500 million.</li>\n <li>Sportradar plays an important, though indirect role in the rapidly growing sports betting industry. However, it faces tough competition.</li>\n <li>Sportradar’s finances are in good shape with high growth and a positive net profit, and its valuation appears low relative to competitors.</li>\n <li>Investors should strongly consider this company when it goes public.</li>\n</ul>\n<p>Sportradar (NASDAQ:SRAD) has released pricing information about its upcoming IPO.Renaissance Capitalreported on Tuesday that Sportradar “plans to raise $504 million by offering 19 million shares at a price range of $25 to $28,” as well as an additional $159 million concurrent private placement. This will give the Swiss company a valuation of $7.8 billion at the midpoint range.</p>\n<p>These numbers may be a tiny disappointment for Sportradar, as it had been reportedly shooting for a$10 billion valuationearlier in the year by undergoing a SPAC. But it is great news for investors, as there is a great deal to like about Sportradar. The sports company is in a market with major growth potential, is profitable, and has been growing rapidly. Concerns remain such as COVID and other competition, but investors should strongly consider getting in on this company as soon as possible especially compared to its main competitors.</p>\n<p><b>Sports Gambling Market Potential</b></p>\n<p>Sports betting has become increasingly accepted and thus a more lucrative market in recent years, as governments have legalized it for the first time.Front Office Sportsreported in June that the US sports betting market could reach $37 billion by 2025 compared to its present value of $9.5 billion. Furthermore, the global sports betting market could reach as much as $144 billion by the same timeframe. And while there are some concerns due to COVID, it is highly unlikely that sports leagues will once again start canceling their events going forward.</p>\n<p>Sportradar’s plan is to be the company selling shovels in this betting gold rush. What it intends to sell is information. Sportradar works with sports leagues across the world to help compile sports data. This data helps betting companies set better odds, helps bettors know that the betting company is not making any mistakes, and helps media companies know that they have the right data.</p>\n<p>The right data is not just about tracking points, home runs, or touchdowns. Sportradar claims in itsF-1/Athat it tracks “over 1.2 billion live data points per year from over 600,000 events in 37 sports,” which created over 21 billion odds changes. Furthermore, Sportradar has a strong data rights portfolio, as it has partnerships with the NBA, MLB, and NHL among other sports leagues across the world.</p>\n<p>These factors point to a company with major growth potential, but then there is the issue of competition. Sportradar’s primary competitor is Genius Sports (NYSE:GENI), which went public this April. After some stumbles a few weeks back, Genius has performed well and has a market cap of $4.23 billion as of the time of writing. While smaller than what Sportradar is aiming for, Genius does have a prized partnership with the NFL and reported a revenue growth of 108% a few days ago perCNBC.</p>\n<p>Sportradar will need to show how it can continue to distinguish itself from its competitors like Genius, as well as Stats Perform, IMGArena, and BetConstruct. But the company has a Dollar-Based Net Retention Rate of 138% which shows an ability to keep customers. Furthermore, the massive potential of the sports betting market means that Sportradar will be able to keep growing without having to poach from competitors.</p>\n<p><b>Finances and Valuation</b></p>\n<p>Sportradar’s growth potential is shown by its finances, where it is the rare tech company which can report both high growth and profitability. The company reported a revenue of $318 million in the first half of 2021, up 42% from the same time period last year. This is probably elevated due to the pandemic depressing 2020 revenue as it only grew 6% in 2020, but Sportradar reports a CAGR of 25% going back to 2016. That is a more reasonable yet still sufficient growth rate.</p>\n<p>Furthermore, Sportradar reported a net income of over $20 million in the first half of 2021 and has a history of profitability going back to at least 2019. Cash flow is also positive, with a net gain of $67 million in cash from operating activities in the first half of 2021.</p>\n<p>Finally, Sportradar reports having $223 million in cash against $967 million in total liabilities. What these numbers show is that Sportradar is rapidly growing, though admittedly not as fast as Genius Sports. But unlike Genius, Sportradar is larger and reports a profit.</p>\n<p></p>\n<p>The next question thus becomes whether Sportradar is worth $7.8 billion. At that market cap, Sportradar has an enterprise value of about $8.5 billion. If we just extrapolate Sportradar’s revenue for the entire year and presume a revenue of $636 million, this gives an EV/revenue ratio of 13.36. By contrast, Genius Sports has an enterprise value of nearly $4 billion, and its first half 2021 revenue was just $109.5 million. From that metric, Sportradar thus appears to be the safer long-term bet.</p>\n<p><b>Final Thoughts</b></p>\n<p>While there is a great deal to like about Sportradar, that does not suggest that there are no problematic clouds on the horizon. I believe that the current COVID situation, where many are reluctant to go outside but sports games are still ongoing, is an excellent situation for Sportradar as people watching from home are more likely to bet online. But if it worsens and sports events are canceled, that would be problematic. If it improves, people may start going for other entertainment options such as casinos which could hurt Sportradar’s growth.</p>\n<p>But Sportradar has shown an ability to consistently grow and is in a market which has major potential almost regardless of the state of COVID. Its financial numbers are in solid shape, and few companies provide a product like what it offers. Finally, its valuation of $7.8 billion is eminently fair, especially by the standards of a typical tech company IPO.</p>\n<p>Investors who chase growth above all else may want to consider Genius, especially as Genius’s lockup period expires soon and it is reasonable to expect a decrease in the price then. But for investors interested in a good tech IPO at a reasonable price, Sportradar will be an excellent fit for most.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SRAD":"Sportradar Group AG"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1149444561","content_text":"Online betting company Sportradar opened at $27 each on Tuesday.\n\nEverything To Like About The Sportradar IPO\nSummary\n\nSportradar Group AG is preparing to go public at a valuation of $7.8 billion and will raise over $500 million.\nSportradar plays an important, though indirect role in the rapidly growing sports betting industry. However, it faces tough competition.\nSportradar’s finances are in good shape with high growth and a positive net profit, and its valuation appears low relative to competitors.\nInvestors should strongly consider this company when it goes public.\n\nSportradar (NASDAQ:SRAD) has released pricing information about its upcoming IPO.Renaissance Capitalreported on Tuesday that Sportradar “plans to raise $504 million by offering 19 million shares at a price range of $25 to $28,” as well as an additional $159 million concurrent private placement. This will give the Swiss company a valuation of $7.8 billion at the midpoint range.\nThese numbers may be a tiny disappointment for Sportradar, as it had been reportedly shooting for a$10 billion valuationearlier in the year by undergoing a SPAC. But it is great news for investors, as there is a great deal to like about Sportradar. The sports company is in a market with major growth potential, is profitable, and has been growing rapidly. Concerns remain such as COVID and other competition, but investors should strongly consider getting in on this company as soon as possible especially compared to its main competitors.\nSports Gambling Market Potential\nSports betting has become increasingly accepted and thus a more lucrative market in recent years, as governments have legalized it for the first time.Front Office Sportsreported in June that the US sports betting market could reach $37 billion by 2025 compared to its present value of $9.5 billion. Furthermore, the global sports betting market could reach as much as $144 billion by the same timeframe. And while there are some concerns due to COVID, it is highly unlikely that sports leagues will once again start canceling their events going forward.\nSportradar’s plan is to be the company selling shovels in this betting gold rush. What it intends to sell is information. Sportradar works with sports leagues across the world to help compile sports data. This data helps betting companies set better odds, helps bettors know that the betting company is not making any mistakes, and helps media companies know that they have the right data.\nThe right data is not just about tracking points, home runs, or touchdowns. Sportradar claims in itsF-1/Athat it tracks “over 1.2 billion live data points per year from over 600,000 events in 37 sports,” which created over 21 billion odds changes. Furthermore, Sportradar has a strong data rights portfolio, as it has partnerships with the NBA, MLB, and NHL among other sports leagues across the world.\nThese factors point to a company with major growth potential, but then there is the issue of competition. Sportradar’s primary competitor is Genius Sports (NYSE:GENI), which went public this April. After some stumbles a few weeks back, Genius has performed well and has a market cap of $4.23 billion as of the time of writing. While smaller than what Sportradar is aiming for, Genius does have a prized partnership with the NFL and reported a revenue growth of 108% a few days ago perCNBC.\nSportradar will need to show how it can continue to distinguish itself from its competitors like Genius, as well as Stats Perform, IMGArena, and BetConstruct. But the company has a Dollar-Based Net Retention Rate of 138% which shows an ability to keep customers. Furthermore, the massive potential of the sports betting market means that Sportradar will be able to keep growing without having to poach from competitors.\nFinances and Valuation\nSportradar’s growth potential is shown by its finances, where it is the rare tech company which can report both high growth and profitability. The company reported a revenue of $318 million in the first half of 2021, up 42% from the same time period last year. This is probably elevated due to the pandemic depressing 2020 revenue as it only grew 6% in 2020, but Sportradar reports a CAGR of 25% going back to 2016. That is a more reasonable yet still sufficient growth rate.\nFurthermore, Sportradar reported a net income of over $20 million in the first half of 2021 and has a history of profitability going back to at least 2019. Cash flow is also positive, with a net gain of $67 million in cash from operating activities in the first half of 2021.\nFinally, Sportradar reports having $223 million in cash against $967 million in total liabilities. What these numbers show is that Sportradar is rapidly growing, though admittedly not as fast as Genius Sports. But unlike Genius, Sportradar is larger and reports a profit.\n\nThe next question thus becomes whether Sportradar is worth $7.8 billion. At that market cap, Sportradar has an enterprise value of about $8.5 billion. If we just extrapolate Sportradar’s revenue for the entire year and presume a revenue of $636 million, this gives an EV/revenue ratio of 13.36. By contrast, Genius Sports has an enterprise value of nearly $4 billion, and its first half 2021 revenue was just $109.5 million. From that metric, Sportradar thus appears to be the safer long-term bet.\nFinal Thoughts\nWhile there is a great deal to like about Sportradar, that does not suggest that there are no problematic clouds on the horizon. I believe that the current COVID situation, where many are reluctant to go outside but sports games are still ongoing, is an excellent situation for Sportradar as people watching from home are more likely to bet online. But if it worsens and sports events are canceled, that would be problematic. If it improves, people may start going for other entertainment options such as casinos which could hurt Sportradar’s growth.\nBut Sportradar has shown an ability to consistently grow and is in a market which has major potential almost regardless of the state of COVID. Its financial numbers are in solid shape, and few companies provide a product like what it offers. Finally, its valuation of $7.8 billion is eminently fair, especially by the standards of a typical tech company IPO.\nInvestors who chase growth above all else may want to consider Genius, especially as Genius’s lockup period expires soon and it is reasonable to expect a decrease in the price then. But for investors interested in a good tech IPO at a reasonable price, Sportradar will be an excellent fit for most.","news_type":1,"symbols_score_info":{"SRAD":0.9}},"isVote":1,"tweetType":1,"viewCount":2060,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":888178732,"gmtCreate":1631468002626,"gmtModify":1676530552086,"author":{"id":"4087621400674580","authorId":"4087621400674580","name":"lalabear","avatar":"https://static.tigerbbs.com/a1763b48ffed5396b0f7f8ce408d9a00","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087621400674580","idStr":"4087621400674580"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/888178732","repostId":"1189654544","repostType":4,"repost":{"id":"1189654544","kind":"news","pubTimestamp":1631406130,"share":"https://ttm.financial/m/news/1189654544?lang=&edition=fundamental","pubTime":"2021-09-12 08:22","market":"us","language":"en","title":"US IPO Week Ahead: The Fall IPO market kicks off with a 10 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1189654544","media":"Renaissance Capital","summary":"After a wave of launches in the short holiday week, 10 IPOs are scheduled to raise over $3 billion i","content":"<p>After a wave of launches in the short holiday week, 10 IPOs are scheduled to raise over $3 billion in the week ahead.</p>\n<p>Tech consultancy&nbsp;<b>Thoughtworks</b>(TWKS) plans to raise $700 million at a $6.3 billion market cap. This agile software developer provides premium, end-to-end digital strategy, design, and engineering services to more than 300 enterprise customers. The company grew revenue at a 14% CAGR from 2017 to 2020, and expanded margins in 2020 and the 1H21.</p>\n<p>Swiss running shoe brand&nbsp;<b>On Holding</b>(ONON) plans to raise $591 million at a $5.9 billion market cap. On is a global provider of premium athletic footwear, apparel, and accessories that are designed using sustainable materials and its proprietary technology. The company has demonstrated growth and profitability, though it faces significant competition from other well-known sportswear brands.</p>\n<p>After ending talks to go public via SPAC,<b>Sportradar Group</b>(SRAD) plans to raise $504 million at a $7.9 billion market cap. Covering over 750,000 events annually across 83 sports, this Swiss company provides software, data, and content to sports leagues, betting operators, and media companies. Sportradar is profitable, and growth accelerated in the 1H21 as live sports resumed.</p>\n<p>Drive-thru coffee chain&nbsp;<b>Dutch Bros</b>(BROS) plans to raise $400 million at a $3.3 billion market cap. This Oregon-based company has a chain of 471 drive-thru coffee shops in the Western US, and it has been able to maintain a track record of same-store sales growth as it has expanded to new states. Insiders received pre-IPO dividends and will sell shares back to the company.</p>\n<p>Healthcare intelligence platform&nbsp;<b>Definitive Healthcare</b>(DH) plans to raise $350 million at a $3.3 billion market cap. This company provides a healthcare commercial intelligence and analytics platform, helping its customers to analyze, navigate, and sell into the complex healthcare ecosystem. Unprofitable with strong growth, Definitive Healthcare will be leveraged post-IPO.</p>\n<p>Identity management platform&nbsp;<b>ForgeRock</b>(FORG) plans to raise $248 million at a $2.1 billion market cap. The company provides identity and access management software, with a platform to provision, authenticate, and govern all types of digital identities. Unprofitable with high sales and marketing expenses, ForgeRock is a leading next-gen provider in the multi-billion-dollar identity and access market.</p>\n<p>Immunology biotech&nbsp;<b>DICE Therapeutics</b>(DICE) plans to raise $160 million at a $550 million market cap. This biotech is developing oral small molecule therapies to treat chronic diseases in immunology and other therapeutic areas. DICE plans to initiate a Phase 1 trial of its lead candidate S011806, an oral antagonist with a variety of immunology indications.</p>\n<p>Surgical robotics developer&nbsp;<b>PROCEPT BioRobotics</b>(PRCT) plans to raise $127 million at a $1.1 billion market cap. This commercial-stage company develops surgical robotic systems for minimally-invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia. PROCEPT BioRobotics is highly unprofitable and saw revenue increase more than sixfold in the 1H21.</p>\n<p>Oncology biotech&nbsp;<b>Tyra Biosciences</b>(TYRA) plans to raise $101 million at a $584 million market cap. This preclinical biotech is developing FGFR kinase inhibitors for cancer, specifically solid tumors. Tyra’s lead candidate is initially focused on bladder cancer, and the company expects to submit an IND for it in mid-2022.</p>\n<p>Micro-cap gas delivery service&nbsp;<b>EzFill Holdings</b>(EZFL) plans to raise $25 million at a $104 million market cap. This mobile-fueling company provides an on-demand fuel delivery service in Florida via mobile app. Highly unprofitable with explosive growth, EzFill states that it is the dominant player in the South Florida market.</p>\n<p><img src=\"https://static.tigerbbs.com/718698ff98644c4026f32efe91d076c6\" tg-width=\"1128\" tg-height=\"684\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/97fe13300d9e4cf61effc59b9706776a\" tg-width=\"1129\" tg-height=\"247\" referrerpolicy=\"no-referrer\"></p>\n<p><b>IPO Market Snapshot</b></p>\n<p>The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 9/9/21, the Renaissance IPO Index was up 7.7% year-to-date, while the S&amp;P 500 was up 19.6%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Palantir Technologies (PLTR). The Renaissance International IPO Index was down 11.0% year-to-date, while the ACWX was up 10.0%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Smoore International and EQT Partners.</p>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: The Fall IPO market kicks off with a 10 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: The Fall IPO market kicks off with a 10 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-12 08:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/85972/US-IPO-Week-Ahead-The-Fall-IPO-market-kicks-off-with-a-10-IPO-week><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After a wave of launches in the short holiday week, 10 IPOs are scheduled to raise over $3 billion in the week ahead.\nTech consultancy Thoughtworks(TWKS) plans to raise $700 million at a $6.3 billion ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/85972/US-IPO-Week-Ahead-The-Fall-IPO-market-kicks-off-with-a-10-IPO-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯","ONON":"On Holding AG","PRCT":"PROCEPT BioRobotics","FORG":"ForgeRock, Inc.",".IXIC":"NASDAQ Composite","BROS":"Dutch Bros Inc.","DICE":"DICE Therapeutics, Inc.","TWKS":"Thoughtworks Holding Inc.",".SPX":"S&P 500 Index","SRAD":"Sportradar Group AG","TYRA":"Tyra Biosciences, Inc.","DH":"Definitive Healthcare Corp."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/85972/US-IPO-Week-Ahead-The-Fall-IPO-market-kicks-off-with-a-10-IPO-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189654544","content_text":"After a wave of launches in the short holiday week, 10 IPOs are scheduled to raise over $3 billion in the week ahead.\nTech consultancy Thoughtworks(TWKS) plans to raise $700 million at a $6.3 billion market cap. This agile software developer provides premium, end-to-end digital strategy, design, and engineering services to more than 300 enterprise customers. The company grew revenue at a 14% CAGR from 2017 to 2020, and expanded margins in 2020 and the 1H21.\nSwiss running shoe brand On Holding(ONON) plans to raise $591 million at a $5.9 billion market cap. On is a global provider of premium athletic footwear, apparel, and accessories that are designed using sustainable materials and its proprietary technology. The company has demonstrated growth and profitability, though it faces significant competition from other well-known sportswear brands.\nAfter ending talks to go public via SPAC,Sportradar Group(SRAD) plans to raise $504 million at a $7.9 billion market cap. Covering over 750,000 events annually across 83 sports, this Swiss company provides software, data, and content to sports leagues, betting operators, and media companies. Sportradar is profitable, and growth accelerated in the 1H21 as live sports resumed.\nDrive-thru coffee chain Dutch Bros(BROS) plans to raise $400 million at a $3.3 billion market cap. This Oregon-based company has a chain of 471 drive-thru coffee shops in the Western US, and it has been able to maintain a track record of same-store sales growth as it has expanded to new states. Insiders received pre-IPO dividends and will sell shares back to the company.\nHealthcare intelligence platform Definitive Healthcare(DH) plans to raise $350 million at a $3.3 billion market cap. This company provides a healthcare commercial intelligence and analytics platform, helping its customers to analyze, navigate, and sell into the complex healthcare ecosystem. Unprofitable with strong growth, Definitive Healthcare will be leveraged post-IPO.\nIdentity management platform ForgeRock(FORG) plans to raise $248 million at a $2.1 billion market cap. The company provides identity and access management software, with a platform to provision, authenticate, and govern all types of digital identities. Unprofitable with high sales and marketing expenses, ForgeRock is a leading next-gen provider in the multi-billion-dollar identity and access market.\nImmunology biotech DICE Therapeutics(DICE) plans to raise $160 million at a $550 million market cap. This biotech is developing oral small molecule therapies to treat chronic diseases in immunology and other therapeutic areas. DICE plans to initiate a Phase 1 trial of its lead candidate S011806, an oral antagonist with a variety of immunology indications.\nSurgical robotics developer PROCEPT BioRobotics(PRCT) plans to raise $127 million at a $1.1 billion market cap. This commercial-stage company develops surgical robotic systems for minimally-invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia. PROCEPT BioRobotics is highly unprofitable and saw revenue increase more than sixfold in the 1H21.\nOncology biotech Tyra Biosciences(TYRA) plans to raise $101 million at a $584 million market cap. This preclinical biotech is developing FGFR kinase inhibitors for cancer, specifically solid tumors. Tyra’s lead candidate is initially focused on bladder cancer, and the company expects to submit an IND for it in mid-2022.\nMicro-cap gas delivery service EzFill Holdings(EZFL) plans to raise $25 million at a $104 million market cap. This mobile-fueling company provides an on-demand fuel delivery service in Florida via mobile app. Highly unprofitable with explosive growth, EzFill states that it is the dominant player in the South Florida market.\n\nIPO Market Snapshot\nThe Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 9/9/21, the Renaissance IPO Index was up 7.7% year-to-date, while the S&P 500 was up 19.6%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Palantir Technologies (PLTR). The Renaissance International IPO Index was down 11.0% year-to-date, while the ACWX was up 10.0%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Smoore International and EQT Partners.","news_type":1,"symbols_score_info":{"TYRA":0.9,"DICE":0.9,"DH":0.9,"FORG":0.9,"TWKS":0.9,".SPX":0.9,".IXIC":0.9,"BROS":0.9,"ONON":0.9,"SRAD":0.9,"EZFL":0.9,"PRCT":0.9,".DJI":0.9}},"isVote":1,"tweetType":1,"viewCount":2233,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":889175961,"gmtCreate":1631121753953,"gmtModify":1676530474534,"author":{"id":"4087621400674580","authorId":"4087621400674580","name":"lalabear","avatar":"https://static.tigerbbs.com/a1763b48ffed5396b0f7f8ce408d9a00","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087621400674580","idStr":"4087621400674580"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/889175961","repostId":"1117517712","repostType":4,"repost":{"id":"1117517712","kind":"news","pubTimestamp":1631114489,"share":"https://ttm.financial/m/news/1117517712?lang=&edition=fundamental","pubTime":"2021-09-08 23:21","market":"us","language":"en","title":"Arqit Quantum Shares Up More Than 45% Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1117517712","media":"MarketWatch","summary":"Shares of quantum encryption technology company Arqit Quantum Inc. are higher on the Nasdaq Wednesda","content":"<p>Shares of quantum encryption technology company Arqit Quantum Inc. are higher on the Nasdaq Wednesday, the company's second day of trading on the exchange.</p>\n<p>At 11:22 a.m. ET, the company's shares were trading 45.58% higher, at $16.45 a share. Volume at the time topped 7.2 million shares.</p>\n<p><img src=\"https://static.tigerbbs.com/7f9111e3de3dfb57b728ef686563c787\" tg-width=\"1405\" tg-height=\"775\" referrerpolicy=\"no-referrer\"></p>\n<p>The stock closed Tuesday with a 35.33% gain, at $11.30 a share.</p>\n<p>Earlier this month, Arqit Quantum closed its business combination with blank-check company Centricus Acquisition Corp.</p>\n<p>Shares of the combined company trade under the symbol ARQQ.</p>\n<p>Trading in the stock was paused earlier Wednesday due to volatility, but has since resumed.</p>\n<p></p>\n<p></p>\n<p></p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Arqit Quantum Shares Up More Than 45% Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nArqit Quantum Shares Up More Than 45% Wednesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-08 23:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/arqit-quantum-shares-up-more-than-40-wednesday-271631114193?mod=newsviewer_click><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of quantum encryption technology company Arqit Quantum Inc. are higher on the Nasdaq Wednesday, the company's second day of trading on the exchange.\nAt 11:22 a.m. ET, the company's shares were ...</p>\n\n<a href=\"https://www.marketwatch.com/story/arqit-quantum-shares-up-more-than-40-wednesday-271631114193?mod=newsviewer_click\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARQQ":"Arqit Quantum Inc."},"source_url":"https://www.marketwatch.com/story/arqit-quantum-shares-up-more-than-40-wednesday-271631114193?mod=newsviewer_click","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1117517712","content_text":"Shares of quantum encryption technology company Arqit Quantum Inc. are higher on the Nasdaq Wednesday, the company's second day of trading on the exchange.\nAt 11:22 a.m. ET, the company's shares were trading 45.58% higher, at $16.45 a share. Volume at the time topped 7.2 million shares.\n\nThe stock closed Tuesday with a 35.33% gain, at $11.30 a share.\nEarlier this month, Arqit Quantum closed its business combination with blank-check company Centricus Acquisition Corp.\nShares of the combined company trade under the symbol ARQQ.\nTrading in the stock was paused earlier Wednesday due to volatility, but has since resumed.","news_type":1,"symbols_score_info":{"ARQQ":0.9}},"isVote":1,"tweetType":1,"viewCount":3011,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":817643865,"gmtCreate":1630947096057,"gmtModify":1676530426512,"author":{"id":"4087621400674580","authorId":"4087621400674580","name":"lalabear","avatar":"https://static.tigerbbs.com/a1763b48ffed5396b0f7f8ce408d9a00","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087621400674580","idStr":"4087621400674580"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/817643865","repostId":"1121396906","repostType":4,"isVote":1,"tweetType":1,"viewCount":3061,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":814485284,"gmtCreate":1630863963148,"gmtModify":1676530407490,"author":{"id":"4087621400674580","authorId":"4087621400674580","name":"lalabear","avatar":"https://static.tigerbbs.com/a1763b48ffed5396b0f7f8ce408d9a00","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087621400674580","idStr":"4087621400674580"},"themes":[],"htmlText":"Agree","listText":"Agree","text":"Agree","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/814485284","repostId":"1157895022","repostType":4,"repost":{"id":"1157895022","kind":"news","pubTimestamp":1630810619,"share":"https://ttm.financial/m/news/1157895022?lang=&edition=fundamental","pubTime":"2021-09-05 10:56","market":"us","language":"en","title":"Beat the market with this quant system that’s very bullish on stocks at record highs","url":"https://stock-news.laohu8.com/highlight/detail?id=1157895022","media":"MarketWatch","summary":"Vance Howard’s HCM Tactical Growth Fund moves you in and out of the stock market when prudent to do ","content":"<blockquote>\n <b>Vance Howard’s HCM Tactical Growth Fund moves you in and out of the stock market when prudent to do so. So far his team of computer scientists’ strategy has paid off.</b>\n</blockquote>\n<p>Imagine you had a money-making machine to harvest gains in the stock market while you sat back to enjoy life.</p>\n<p>That’s everyone’s dream, right? Investor Vance Howard thinks he’s found it.</p>\n<p>Howard and his small army of computer programmers atHoward Capital Managementin Roswell, Ga., have a quantitative system that posts great returns.</p>\n<p>His HCM Tactical Growth Fund&nbsp;HCMGX,+0.35%beats its Russell 1000&nbsp;benchmark index and large-blend fund category by 8.5-10.4 percentage points annualized over the past five years, according to Morningstar. That is no small feat, and not only because it has to overcome a 2.22% fee. Beating the market is simply not easy. His HCM Dividend Sector PlusHCMQX,-0.05%) and HCM Income PlusHCMLX,+0.30%funds post similar outperformance.</p>\n<p>There are drawbacks, which I detail below. (Among them: Potentially long stretches of underperformance and regular tax bills.) But first, what can we learn from this winner?</p>\n<p>So-called quants never share all the details of their proprietary systems, but Howard shares a lot, as you’ll see. And this Texas rancher has a lot of good advice based on “horse sense” — not surprising, given his infectious passion for the markets, and his three decades of experience as a pro.</p>\n<p>Here are five lessons, 12 exchange traded funds (ETFs) and four stocks to consider, from a recent interview with him.</p>\n<p><b>Lesson #1: Don’t be emotional</b></p>\n<p>It’s no surprise so many people do poorly in the market. Evolution has programmed us to fail. For survival, we’ve learned to run from things that frightens us. And crave more of things that are pleasurable — like sweets or fats to store calories ahead of what might be a long stretch without food. But in the market, acting on the emotions of fear and greed invariably make us do the wrong thing at the wrong time. Sell at the bottom, buy at the top.</p>\n<p>Likewise, we’re programmed to believe being with the crowd brings safety. If you’re a zebra on the Savanna, you are more likely to get picked off by a predator if you go it alone. The problem here is being part of a crowd — and crowd psychology — dumb us down to a purely emotional level. This is why people in crowds do terrible things they would never do on their own. It doesn’t matter how smart you are. When you join a crowd, you lose a lot of IQ points. Base emotions take over.</p>\n<p>To do well in the market, you have to counteract these tendencies. “One of the biggest mistakes individual investors and money managers make is getting emotional,” says Howard. “Let your emotions go.”</p>\n<p><b>Lesson #2: Have a system and stick to it</b></p>\n<p>To exorcise emotion, have a system. “And don’t second guess it,” says Howard. “This keeps you from letting the pandemic or Afghanistan scare you out of the market.” He calls his system the HCM-BuyLine. It is basically a momentum and trend-following system — which often works well in the markets.</p>\n<p>The HCM-BuyLine basically works like this. First, rather than use the S&amp;P 500SPX,-0.03%or the Dow Jones Industrial AverageDJIA,-0.21%,Howard blends several stock indices to create his own index. Then he uses a moving average that tells him whether the market is in an uptrend or downtrend.</p>\n<p>When the moving average drops 3.5%, he sells 35%. If it drops 6.5%, he sells another 35%. He rarely goes to 100% cash.</p>\n<p>“If the BuyLine is positive, we will stay long no matter what,” he says. “We take all the emotion out of the equation by letting the math decide.”</p>\n<p>Right now, it’s bullish. (More on this below.)</p>\n<p>Your system also has to tell you when to get back in.</p>\n<p>“That’s where most people screw up,” he says. “They get out of the market, and they don’t know when to get back in.” The HCM-BuyLine gives a buy signal when his custom index trades above its moving average for six consecutive sessions, and then goes on to trade above the high hit during those six days.</p>\n<p>You don’t need a system that calls exact market tops or bottoms. Instead, the BuyLine keeps Howard out of down markets 85% of the time, and in for 85% of the good times.</p>\n<p>“If we can do that consistently, we have superior returns and a less stressful life,” he says. “Being all in during a bad tape is no fun.”</p>\n<p>His system is slow to get him out of the market, but quick to get him back in. Not even a 10% correction will necessarily move him out. He’s often buying those pullbacks. Getting back in fast makes sense, because recoveries off bottoms tend to happen fast.</p>\n<p>“The HCM-BuyLine takes all the emotion out of the process,” says Howard.</p>\n<p><b>Lesson #3: Don’t fight the tape</b></p>\n<p>This concept is one of the core pieces of wisdom from Marty Zweig’s classic book, “Winning on Wall Street.”</p>\n<p>“You have to stay on the right side of market,” agrees Howard. “If you try to trade long in a bad market, it is painful.”</p>\n<p>In other words, don’t try to be a hero.</p>\n<p>“Sometimes, not losing money is where you want to be,” he says.</p>\n<p>Likewise, don’t turn cautious just because the market hits new highs — like now. You should love new highs, because it is a sign of market strength that may likely endure.</p>\n<p><b>Lesson #4: Keep it simple</b></p>\n<p>As you’ll see below, Howard doesn’t use esoteric instruments such as derivatives, swaps or index options. He doesn’t even trade foreign stocks or currencies. This is refreshing for individual investors, because we have a harder time accessing those tools.</p>\n<p>“You don’t have to trade crazy stuff,” he says. “You can trade plain-vanilla ETFs and beat everybody out there.”</p>\n<p><b>Lesson #5: How to trade the current market</b></p>\n<p>First, be long.</p>\n<p>“The HCM-BuyLine is very positive. We are 100% in,” says Howard. “The market is broadening out. It is getting pretty exciting. We do not see it turn around any time soon. We are buying pullbacks.”</p>\n<p>One bullish signal is all the cash on the sidelines. “If there is any relief in Covid, we may see a big rally. We may end up with a great fall [season].”</p>\n<p>Howard uses momentum indicators to select stocks and ETFs, too. For sectors he favors the following.</p>\n<p>He likes health care, tradable through the iShares US HealthcareIYH,-0.04%and ProShares Ultra Health CareRXL,+0.12%ETFs. He’s turning more bullish on biotech, which he plays via the iShares Biotechnology ETFIBB,-0.11%.</p>\n<p>He likes consumer discretionary tradable through the iShares US Consumer ServicesIYC,-0.30%,and airlines via US Global JetsJETS,-1.17%.He also likes tech exposure via the Invesco QQQ TrustQQQ,+0.31%,iShares US TechnologyIYW,+0.50%and&nbsp;iShares SemiconductorSOXX,+0.75%.</p>\n<p>He likes small-caps via the Vanguard Small-Cap Growth Index FundVBK,+0.07%.And convertible bonds via SPDR Bloomberg Barclays Convertible SecuritiesCWB,+0.64%and iShares Convertible BondICVT,+0.37%.</p>\n<p>As for individual names, he singles out MicrosoftMSFT,-0.00%and AppleAAPL,+0.42%in tech, as well as Amazon.comAMZN,+0.43%and TeslaTSLA,+0.16%.</p>\n<p>Also consider Howard’s two ETFs: The HCM Defender 100 IndexQQH,+0.62%and HCM Defender 500 IndexLGH,+1.32%.</p>\n<p>He prefers to add to holdings on 1%-3% dips.</p>\n<p><b>A few drawbacks</b></p>\n<p>His HCM Tactical Growth fund has a history of posting two-year stretches of underperformance of 1.5% to 8.8%, since it was launched in 2015. The fund then came roaring back to net the very positive five-year outperformance cited above. Investing in his system can require patience.</p>\n<p>Every manager, including Warren Buffett, can have a stretch of underperformance, says Howard.</p>\n<p>“We are in the odds game,” he says. “Even in the odds game, you can have a bad hand or two thrown at you.”</p>\n<p>Another challenge is the high turnover, which is 140% a year for Tactical Growth. This means Uncle Sam takes a big cut in the good years. So if you buy Howard’s funds, you may want to do so in a tax-protected account.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Beat the market with this quant system that’s very bullish on stocks at record highs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeat the market with this quant system that’s very bullish on stocks at record highs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-05 10:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/beat-the-market-with-this-quant-system-thats-very-bullish-on-stocks-at-record-highs-11630761531?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Vance Howard’s HCM Tactical Growth Fund moves you in and out of the stock market when prudent to do so. So far his team of computer scientists’ strategy has paid off.\n\nImagine you had a money-making ...</p>\n\n<a href=\"https://www.marketwatch.com/story/beat-the-market-with-this-quant-system-thats-very-bullish-on-stocks-at-record-highs-11630761531?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite","SPY":"标普500ETF",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"source_url":"https://www.marketwatch.com/story/beat-the-market-with-this-quant-system-thats-very-bullish-on-stocks-at-record-highs-11630761531?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1157895022","content_text":"Vance Howard’s HCM Tactical Growth Fund moves you in and out of the stock market when prudent to do so. So far his team of computer scientists’ strategy has paid off.\n\nImagine you had a money-making machine to harvest gains in the stock market while you sat back to enjoy life.\nThat’s everyone’s dream, right? Investor Vance Howard thinks he’s found it.\nHoward and his small army of computer programmers atHoward Capital Managementin Roswell, Ga., have a quantitative system that posts great returns.\nHis HCM Tactical Growth Fund HCMGX,+0.35%beats its Russell 1000 benchmark index and large-blend fund category by 8.5-10.4 percentage points annualized over the past five years, according to Morningstar. That is no small feat, and not only because it has to overcome a 2.22% fee. Beating the market is simply not easy. His HCM Dividend Sector PlusHCMQX,-0.05%) and HCM Income PlusHCMLX,+0.30%funds post similar outperformance.\nThere are drawbacks, which I detail below. (Among them: Potentially long stretches of underperformance and regular tax bills.) But first, what can we learn from this winner?\nSo-called quants never share all the details of their proprietary systems, but Howard shares a lot, as you’ll see. And this Texas rancher has a lot of good advice based on “horse sense” — not surprising, given his infectious passion for the markets, and his three decades of experience as a pro.\nHere are five lessons, 12 exchange traded funds (ETFs) and four stocks to consider, from a recent interview with him.\nLesson #1: Don’t be emotional\nIt’s no surprise so many people do poorly in the market. Evolution has programmed us to fail. For survival, we’ve learned to run from things that frightens us. And crave more of things that are pleasurable — like sweets or fats to store calories ahead of what might be a long stretch without food. But in the market, acting on the emotions of fear and greed invariably make us do the wrong thing at the wrong time. Sell at the bottom, buy at the top.\nLikewise, we’re programmed to believe being with the crowd brings safety. If you’re a zebra on the Savanna, you are more likely to get picked off by a predator if you go it alone. The problem here is being part of a crowd — and crowd psychology — dumb us down to a purely emotional level. This is why people in crowds do terrible things they would never do on their own. It doesn’t matter how smart you are. When you join a crowd, you lose a lot of IQ points. Base emotions take over.\nTo do well in the market, you have to counteract these tendencies. “One of the biggest mistakes individual investors and money managers make is getting emotional,” says Howard. “Let your emotions go.”\nLesson #2: Have a system and stick to it\nTo exorcise emotion, have a system. “And don’t second guess it,” says Howard. “This keeps you from letting the pandemic or Afghanistan scare you out of the market.” He calls his system the HCM-BuyLine. It is basically a momentum and trend-following system — which often works well in the markets.\nThe HCM-BuyLine basically works like this. First, rather than use the S&P 500SPX,-0.03%or the Dow Jones Industrial AverageDJIA,-0.21%,Howard blends several stock indices to create his own index. Then he uses a moving average that tells him whether the market is in an uptrend or downtrend.\nWhen the moving average drops 3.5%, he sells 35%. If it drops 6.5%, he sells another 35%. He rarely goes to 100% cash.\n“If the BuyLine is positive, we will stay long no matter what,” he says. “We take all the emotion out of the equation by letting the math decide.”\nRight now, it’s bullish. (More on this below.)\nYour system also has to tell you when to get back in.\n“That’s where most people screw up,” he says. “They get out of the market, and they don’t know when to get back in.” The HCM-BuyLine gives a buy signal when his custom index trades above its moving average for six consecutive sessions, and then goes on to trade above the high hit during those six days.\nYou don’t need a system that calls exact market tops or bottoms. Instead, the BuyLine keeps Howard out of down markets 85% of the time, and in for 85% of the good times.\n“If we can do that consistently, we have superior returns and a less stressful life,” he says. “Being all in during a bad tape is no fun.”\nHis system is slow to get him out of the market, but quick to get him back in. Not even a 10% correction will necessarily move him out. He’s often buying those pullbacks. Getting back in fast makes sense, because recoveries off bottoms tend to happen fast.\n“The HCM-BuyLine takes all the emotion out of the process,” says Howard.\nLesson #3: Don’t fight the tape\nThis concept is one of the core pieces of wisdom from Marty Zweig’s classic book, “Winning on Wall Street.”\n“You have to stay on the right side of market,” agrees Howard. “If you try to trade long in a bad market, it is painful.”\nIn other words, don’t try to be a hero.\n“Sometimes, not losing money is where you want to be,” he says.\nLikewise, don’t turn cautious just because the market hits new highs — like now. You should love new highs, because it is a sign of market strength that may likely endure.\nLesson #4: Keep it simple\nAs you’ll see below, Howard doesn’t use esoteric instruments such as derivatives, swaps or index options. He doesn’t even trade foreign stocks or currencies. This is refreshing for individual investors, because we have a harder time accessing those tools.\n“You don’t have to trade crazy stuff,” he says. “You can trade plain-vanilla ETFs and beat everybody out there.”\nLesson #5: How to trade the current market\nFirst, be long.\n“The HCM-BuyLine is very positive. We are 100% in,” says Howard. “The market is broadening out. It is getting pretty exciting. We do not see it turn around any time soon. We are buying pullbacks.”\nOne bullish signal is all the cash on the sidelines. “If there is any relief in Covid, we may see a big rally. We may end up with a great fall [season].”\nHoward uses momentum indicators to select stocks and ETFs, too. For sectors he favors the following.\nHe likes health care, tradable through the iShares US HealthcareIYH,-0.04%and ProShares Ultra Health CareRXL,+0.12%ETFs. He’s turning more bullish on biotech, which he plays via the iShares Biotechnology ETFIBB,-0.11%.\nHe likes consumer discretionary tradable through the iShares US Consumer ServicesIYC,-0.30%,and airlines via US Global JetsJETS,-1.17%.He also likes tech exposure via the Invesco QQQ TrustQQQ,+0.31%,iShares US TechnologyIYW,+0.50%and iShares SemiconductorSOXX,+0.75%.\nHe likes small-caps via the Vanguard Small-Cap Growth Index FundVBK,+0.07%.And convertible bonds via SPDR Bloomberg Barclays Convertible SecuritiesCWB,+0.64%and iShares Convertible BondICVT,+0.37%.\nAs for individual names, he singles out MicrosoftMSFT,-0.00%and AppleAAPL,+0.42%in tech, as well as Amazon.comAMZN,+0.43%and TeslaTSLA,+0.16%.\nAlso consider Howard’s two ETFs: The HCM Defender 100 IndexQQH,+0.62%and HCM Defender 500 IndexLGH,+1.32%.\nHe prefers to add to holdings on 1%-3% dips.\nA few drawbacks\nHis HCM Tactical Growth fund has a history of posting two-year stretches of underperformance of 1.5% to 8.8%, since it was launched in 2015. The fund then came roaring back to net the very positive five-year outperformance cited above. Investing in his system can require patience.\nEvery manager, including Warren Buffett, can have a stretch of underperformance, says Howard.\n“We are in the odds game,” he says. “Even in the odds game, you can have a bad hand or two thrown at you.”\nAnother challenge is the high turnover, which is 140% a year for Tactical Growth. This means Uncle Sam takes a big cut in the good years. So if you buy Howard’s funds, you may want to do so in a tax-protected account.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,"SPY":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":2121,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":816467960,"gmtCreate":1630514774150,"gmtModify":1676530328129,"author":{"id":"4087621400674580","authorId":"4087621400674580","name":"lalabear","avatar":"https://static.tigerbbs.com/a1763b48ffed5396b0f7f8ce408d9a00","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087621400674580","idStr":"4087621400674580"},"themes":[],"htmlText":"Yes","listText":"Yes","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/816467960","repostId":"2164813941","repostType":4,"isVote":1,"tweetType":1,"viewCount":2021,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":818465863,"gmtCreate":1630428235352,"gmtModify":1676530301807,"author":{"id":"4087621400674580","authorId":"4087621400674580","name":"lalabear","avatar":"https://static.tigerbbs.com/a1763b48ffed5396b0f7f8ce408d9a00","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4087621400674580","idStr":"4087621400674580"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/818465863","repostId":"1166102613","repostType":4,"isVote":1,"tweetType":1,"viewCount":3036,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}